Original language | English |
---|---|
Pages (from-to) | 1017-1022 |
Number of pages | 6 |
Journal | Clinical chemistry |
Volume | 59 |
Issue number | 7 |
DOIs |
|
State | Published - Jul 2013 |
FDA oversight of laboratory-developed tests: Is it necessary, and how would it impact clinical laboratories?
Mitchell G. Scott, Edward R. Ashwood, Thomas M. Annesley, Debra G.B. Leonard, Michael C. Burgess
Research output: Contribution to journal › Comment/debate
9
Scopus
citations